Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $405,010 | 179 | 68.3% |
| Consulting Fee | $85,681 | 29 | 14.5% |
| Travel and Lodging | $60,189 | 221 | 10.2% |
| Honoraria | $24,905 | 14 | 4.2% |
| Food and Beverage | $16,848 | 292 | 2.8% |
| Education | $142.87 | 7 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $452,939 | 566 | $0 (2024) |
| ViiV Healthcare Company | $43,775 | 46 | $0 (2023) |
| Janssen Products, LP | $38,625 | 49 | $0 (2023) |
| Theratechnologies Inc. | $35,826 | 43 | $0 (2021) |
| Merck Sharp & Dohme LLC | $21,393 | 27 | $0 (2024) |
| Janssen Biotech, Inc. | $218.71 | 11 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,189 | 20 | Gilead Sciences, Inc. ($5,492) |
| 2023 | $72,258 | 100 | Gilead Sciences, Inc. ($59,479) |
| 2022 | $32,498 | 31 | Gilead Sciences, Inc. ($21,777) |
| 2021 | $38,160 | 36 | Gilead Sciences, Inc. ($24,458) |
| 2020 | $71,095 | 68 | Gilead Sciences, Inc. ($49,976) |
| 2019 | $157,365 | 204 | Gilead Sciences, Inc. ($112,977) |
| 2018 | $120,689 | 159 | Gilead Sciences, Inc. ($94,935) |
| 2017 | $94,523 | 124 | Gilead Sciences Inc ($83,845) |
All Payment Transactions
742 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Gilead Sciences, Inc. | Sunlenca (Drug) | Food and Beverage | In-kind items and services | $50.93 | General |
| Category: HIV | ||||||
| 12/06/2024 | Gilead Sciences, Inc. | Sunlenca (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: HIV | ||||||
| 12/06/2024 | Gilead Sciences, Inc. | Sunlenca (Drug) | Food and Beverage | In-kind items and services | $28.35 | General |
| Category: HIV | ||||||
| 12/06/2024 | Gilead Sciences, Inc. | Sunlenca (Drug) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: HIV | ||||||
| 12/06/2024 | Gilead Sciences, Inc. | Sunlenca (Drug) | Travel and Lodging | In-kind items and services | $25.55 | General |
| Category: HIV | ||||||
| 12/06/2024 | Gilead Sciences, Inc. | Sunlenca (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: HIV | ||||||
| 10/09/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $697.50 | General |
| 09/08/2024 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $19.99 | General |
| 05/07/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $349.00 | General |
| 05/07/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $195.62 | General |
| 05/07/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $55.77 | General |
| 05/07/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $24.97 | General |
| 03/25/2024 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,350.00 | General |
| 03/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $43.42 | General |
| 03/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $43.42 | General |
| 03/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $43.42 | General |
| 03/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $43.42 | General |
| 03/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $40.50 | General |
| 03/06/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $79.81 | General |
| 03/06/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.09 | General |
| 12/21/2023 | ViiV Healthcare Company | CABENUVA (Biological) | Consulting Fee | Cash or cash equivalent | $5,200.00 | General |
| Category: HIV | ||||||
| 12/21/2023 | ViiV Healthcare Company | CABENUVA (Biological) | Travel and Lodging | Cash or cash equivalent | $110.86 | General |
| Category: HIV | ||||||
| 11/28/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $63.76 | General |
| 11/28/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 11/28/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $50.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 281 | 589 | $153,159 | $76,592 |
| 2022 | 4 | 281 | 561 | $143,200 | $70,077 |
| 2021 | 5 | 325 | 520 | $122,887 | $57,346 |
| 2020 | 5 | 330 | 735 | $180,386 | $71,883 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 135 | 295 | $84,665 | $44,796 | 52.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 89 | 153 | $37,485 | $16,492 | 44.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 27 | 110 | $22,330 | $11,496 | 51.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $6,579 | $2,614 | 39.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 14 | $2,100 | $1,194 | 56.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 125 | 235 | $67,445 | $35,394 | 52.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 121 | 252 | $61,740 | $28,098 | 45.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 19 | 55 | $11,165 | $4,973 | 44.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 19 | $2,850 | $1,612 | 56.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 105 | 171 | $49,077 | $24,318 | 49.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 112 | 172 | $42,140 | $18,654 | 44.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 60 | 106 | $15,052 | $6,807 | 45.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 33 | 35 | $9,310 | $4,243 | 45.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 15 | 36 | $7,308 | $3,324 | 45.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 140 | 285 | $81,795 | $32,865 | 40.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 123 | 293 | $71,785 | $26,700 | 37.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 27 | 72 | $14,616 | $6,777 | 46.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 25 | 70 | $9,940 | $4,569 | 46.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 15 | 15 | $2,250 | $972.83 | 43.2% |
About Dr. Jeffrey Burack, M.D
Dr. Jeffrey Burack, M.D is a Internal Medicine healthcare provider based in Oakland, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316967474.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Burack, M.D has received a total of $592,777 in payments from pharmaceutical and medical device companies, with $6,189 received in 2024. These payments were reported across 742 transactions from 6 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($405,010).
As a Medicare-enrolled provider, Burack has provided services to 1,217 Medicare beneficiaries, totaling 2,405 services with total Medicare billing of $275,899. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Oakland, CA
- Active Since 07/20/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1316967474
Products in Payments
- Biktarvy (Drug) $128,299
- Truvada (Drug) $56,562
- TROGARZO (Drug) $33,976
- Epclusa (Drug) $27,136
- Sunlenca (Drug) $25,043
- Descovy (Drug) $16,485
- Genvoya (Drug) $13,277
- PREZCOBIX (Drug) $11,870
- PIFELTRO (Drug) $11,859
- Symtuza (Drug) $10,777
- SYMTUZA (Drug) $10,002
- DOVATO (Drug) $6,660
- CABENUVA (Biological) $5,317
- Vosevi (Drug) $4,362
- TIVICAY (Drug) $3,943
- DELSTRIGO (Drug) $3,213
- Odefsey (Drug) $2,780
- ISENTRESS (Drug) $2,438
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Oakland
Stephanie Christenson, Md, MD
Internal Medicine — Payments: $424,755
Robert Hagar, M.d, M.D
Internal Medicine — Payments: $70,113
Min Yan, M.d, M.D
Internal Medicine — Payments: $45,508
Anita Chang, Md, MD
Internal Medicine — Payments: $27,813
Dr. Robert Bober, Md, MD
Internal Medicine — Payments: $26,112
Oluwayemisi Adejumo, M.d, M.D
Internal Medicine — Payments: $23,341